MORC3 and dermatomyositis: Regarding disease subtypes, 60 (38.5%) patients had ASS, 84 (53.8%) had anti-MDA5+DM, and 12 (7.7%) had other positive antibodies, including Mi-2, TIFγ, NXP2, SAE, PM-Scl75.